We studied an extensive material of 152 non-BRCA1/2 tumours, and also 110 tumours from BRCA1/2 families for histopathological features as well as for the immunohistochemical expression of ER, PgR, p53 and erbB2. This evidence concerns the gene BRCA1 and neoplasm.